Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
- PMID: 18834855
- DOI: 10.1016/j.bbrc.2008.09.086
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Abstract
Tumor suppressor p53 transcriptionally regulates expression of microRNA-34a, which confers translational inhibition and mRNA degradation of genes involved in cell cycle control and apoptosis. In various cancers, miR-34a expression is lost or reduced. Here, we investigated the role of miR-34a in prostate cancer cell lines. MiR-34a expression was markedly reduced in p53-null PC3 cells and p53-mutated DU145 cells compared with LNCaP cells expressing wild-type p53. In PC3 cell, ectopic expression of miR-34a decreased the SIRT1 mRNA and protein levels as well as protein levels of known direct target genes. Reporter assays revealed that miR-34a-induced SIRT1 inhibition occurred at the transcriptional but not post-transcriptional level despite the presence of a potential miR-34a binding site within its 3'-UTR. Ectopic miR-34a expression resulted in cell cycle arrest and growth inhibition and attenuated chemoresistance to anticancer drug camptothecin by inducing apoptosis, suggesting a potential role of miR-34a for the treatment of p53-defective prostate cancer.
Similar articles
-
MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.Prostate. 2010 Oct 1;70(14):1501-12. doi: 10.1002/pros.21185. Prostate. 2010. PMID: 20687223
-
MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007. Arch Med Res. 2010. PMID: 20470934
-
The miR-34 family in cancer and apoptosis.Cell Death Differ. 2010 Feb;17(2):193-9. doi: 10.1038/cdd.2009.56. Epub 2009 May 22. Cell Death Differ. 2010. PMID: 19461653 Review.
-
A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells.Biochem Biophys Res Commun. 2008 Aug 29;373(3):423-8. doi: 10.1016/j.bbrc.2008.06.045. Epub 2008 Jun 23. Biochem Biophys Res Commun. 2008. PMID: 18573234
-
p53 enters the microRNA world.Cancer Cell. 2007 Nov;12(5):414-8. doi: 10.1016/j.ccr.2007.10.028. Cancer Cell. 2007. PMID: 17996645 Review.
Cited by
-
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation.Cancer Metastasis Rev. 2024 Mar;43(1):229-260. doi: 10.1007/s10555-024-10168-9. Epub 2024 Feb 19. Cancer Metastasis Rev. 2024. PMID: 38374496 Review.
-
Bioinformatics-Assisted Extraction of All PCa miRNAs and their Target Genes.Microrna. 2024;13(1):33-55. doi: 10.2174/0122115366253242231020053221. Microrna. 2024. PMID: 38284737
-
Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules.Life (Basel). 2023 Sep 27;13(10):1976. doi: 10.3390/life13101976. Life (Basel). 2023. PMID: 37895357 Free PMC article. Review.
-
Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.PLoS One. 2023 Oct 13;18(10):e0292880. doi: 10.1371/journal.pone.0292880. eCollection 2023. PLoS One. 2023. PMID: 37831728 Free PMC article.
-
Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms.Cancers (Basel). 2023 Jun 10;15(12):3140. doi: 10.3390/cancers15123140. Cancers (Basel). 2023. PMID: 37370750 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
